scispace - formally typeset
J

Julie Bastien

Researcher at Novartis

Publications -  5
Citations -  572

Julie Bastien is an academic researcher from Novartis. The author has contributed to research in topics: Autophagy & Human mitochondrial genetics. The author has an hindex of 3, co-authored 5 publications receiving 395 citations.

Papers
More filters
Journal ArticleDOI

Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivo

TL;DR: During human stem cell division, cells not only tolerate high mtDNA deletion loads but seem to preferentially replicate deleted mtDNA genomes, which has implications for the involvement of mtDNA deletions in both disease and ageing.
Journal ArticleDOI

Stendomycin selectively inhibits TIM23-dependent mitochondrial protein import

TL;DR: It is shown that the natural product stendomycin, produced by Streptomyces hygroscopicus, is a potent and specific inhibitor of the TIM23 complex in yeast and mammalian cells and that TIM23 is required to stabilize PINK1 on the outside of mitochondria to initiate mitophagy upon membrane depolarization.
Journal ArticleDOI

Molecular targets and approaches to restore autophagy and lysosomal capacity in neurodegenerative disorders.

TL;DR: In this article, the authors conceptualized mechanistic and genetic evidence pointing towards autophagy and lysosomal dysfunction as a causal driver of neurodegeneration and discussed rate-limiting pathway nodes and potential approaches to restore pathway activity.